Zhuang J - Search Results

1

Chemokine Receptor 4-Targeted PET/CT with [⁶⁸Ga]pentixather in Newly Diagnosed Multiple Myeloma: a Comparative Study with [⁶⁸Ga]pentixafor PET/CT.

Yang Q, Zhang F, Hao Z, Zhuang J, Huo L. Yang Q, et al. Among authors: zhuang j. Mol Imaging Biol. 2024 Dec;26(6):986-994. doi: 10.1007/s11307-024-01953-7. Epub 2024 Sep 20. Mol Imaging Biol. 2024. PMID: 39304574

2

11C-acetate positron emission tomography is more precise than 18F-fluorodeoxyglucose positron emission tomography in evaluating tumor burden and predicting disease risk of multiple myeloma.

Chen M, Zhu W, Du J, Yang C, Han B, Zhou D, Huo L, Zhuang J. Chen M, et al. Among authors: zhuang j. Sci Rep. 2021 Nov 12;11(1):22188. doi: 10.1038/s41598-021-01740-2. Sci Rep. 2021. PMID: 34773054 Free PMC article.

3

Pathophysiology and therapeutic advances in myeloma bone disease.

Zhang F, Zhuang J. Zhang F, et al. Among authors: zhuang j. Chronic Dis Transl Med. 2022 Jul 4;8(4):264-270. doi: 10.1002/cdt3.35. eCollection 2022 Dec. Chronic Dis Transl Med. 2022. PMID: 36420171 Free PMC article. Review.

4

[The influencing factors of renal response in newly diagnosed multiple myeloma patients with renal impairment].

Song YH, Zhang FJ, Hu RR, Chen M, Yang C, Wang W, Qin Y, Zhou DB, Zhuang JL. Song YH, et al. Among authors: zhuang jl. Zhonghua Xue Ye Xue Za Zhi. 2023 Feb 14;44(2):141-147. doi: 10.3760/cma.j.issn.0253-2727.2023.02.010. Zhonghua Xue Ye Xue Za Zhi. 2023. PMID: 36948869 Free PMC article. Chinese.

5

[Efficacy and prognostic analysis of orthopedic surgery in patients with newly diagnosed multiple myeloma].

Zhang FJ, Zhou X, Liu SZ, Liu SJ, Liu Y, Zhuang JL. Zhang FJ, et al. Among authors: zhuang jl. Zhonghua Nei Ke Za Zhi. 2023 Jun 1;62(6):673-680. doi: 10.3760/cma.j.cn112138-20220824-00621. Zhonghua Nei Ke Za Zhi. 2023. PMID: 37263950 Chinese.

6

Complete blood and urine paraprotein tests as response assessments in multiple myeloma patients treated with bortezomib, cyclophosphamide, and dexamethasone.

Lan X, Zhang F, Yang C, Su W, Du J, Liu S, Chen M, Han B, Zhou D, Zhuang J. Lan X, et al. Among authors: zhuang j. Chronic Dis Transl Med. 2023 Oct 31;10(1):62-68. doi: 10.1002/cdt3.99. eCollection 2024 Mar. Chronic Dis Transl Med. 2023. PMID: 38450304 Free PMC article.

7

Chemokine Receptor 4-Targeted PET/CT With 68 Ga-Pentixather Detects More Lesions Than 68 Ga-Pentixafor PET/CT in Multiple Myeloma.

Yang Q, Zhang F, Hao Z, Zhuang J, Huo L. Yang Q, et al. Among authors: zhuang j. Clin Nucl Med. 2024 Jun 1;49(6):592-593. doi: 10.1097/RLU.0000000000005194. Epub 2024 Apr 17. Clin Nucl Med. 2024. PMID: 38630995

8

[The 505th case: refractory ascites and monoclonal immunoglobulin].

Zhang FJ, Zheng WY, Wang X, Jiang XY, Zhuang JL. Zhang FJ, et al. Among authors: zhuang jl. Zhonghua Nei Ke Za Zhi. 2024 May 1;63(5):517-520. doi: 10.3760/cma.j.cn112138-20231208-00373. Zhonghua Nei Ke Za Zhi. 2024. PMID: 38715493 Chinese.

9

Myc rearrangement redefines the stratification of high-risk multiple myeloma.

Jin X, Li H, Zhang D, Liu S, Song Y, Zhang F, Li Z, Zhuang J. Jin X, et al. Among authors: zhuang j. Cancer Med. 2024 Jun;13(11):e7194. doi: 10.1002/cam4.7194. Cancer Med. 2024. PMID: 38845529 Free PMC article.

10

Impaired acute-phase humoral immunity is the major factor predicting unfavorable outcomes in multiple myeloma patients with SARS-CoV-2 Omicron variants outbreak infection.

Li Z, He H, Li H, Zhang F, Jin X, Liu S, Chen M, Li Y, Zhuang J. Li Z, et al. Among authors: zhuang j. Int J Cancer. 2024 Oct 15;155(8):1500-1509. doi: 10.1002/ijc.35063. Epub 2024 Jun 25. Int J Cancer. 2024. PMID: 38922877

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,450 results

Search Page

Filters